At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are, allowing you to thrive both personally and professionally. This is how we aim to prevent, stop and cure diseases and ensure everyone has access to healthcare today and for generations to come. Join Roche, where every voice matters.
The PositionMain Purpose
To serve as a strategic architect for patient access in the complex Bulgarian healthcare market. This role is responsible for identifying and dismantling barriers to access through innovative pricing strategies, value-based healthcare solutions, and high-level stakeholder collaborations. As a MA & Pricing Enabler, you will empower a cross-functional team to create optimal access for Roche’s portfolio and pipeline, ensuring Bulgarian patients receive innovative medicines faster and more sustainably.
Core Accountabilities
1. Strategic Access & Innovative Solutions
● Develop and implement the long-term access and pricing strategy for the entire disease area portfolio and future pipeline.
● Architect innovative access solutions, including Risk-Sharing Agreements, Outcomes-Based Agreements (OBA), and Alternative Reimbursement Models (ARMs) to address local budget constraints.
● Lead the co-creation of healthcare capacity solutions in partnership with Health System Partners (HSPs) and Global Access teams.
● Synthesize and localize global pharmaco-economic models to reflect the Bulgarian healthcare landscape and HTA requirements.
2. Pricing & Value Strategy
● Design and execute comprehensive pricing strategies that account for the local healthcare environment, international reference pricing, and launch sequencing.
● Lead all aspects of reimbursement submissions, ensuring robust value propositions and successful negotiations with Bulgarian authorities.
● Establish and monitor floor price compliance and commercial arrangements to maintain portfolio competitiveness and business sustainability.
● Review and escalate pricing business cases, providing critical assumptions to inform valuations for senior leadership.
● Achieve access for Roche’s priority and new products
3. Health Policy & System Shaping
● Influence the policy agenda by analyzing legislation and evaluating the impact of proposed healthcare reforms on the pharmaceutical sector.
● Build and uphold strategic relationships with key influencers, including the Ministry of Health, NCPR and NHIF.
● Represent Roche in industry organizations to advance legislative interests and protect the company’s reputation as a trustworthy partner.
4. Internal Collaboration
● Act as a senior cross-functional enabler, challenging individuals at all levels to find creative solutions to access hurdles.
● Empower a team, fostering a growth mindset and a culture of accountability and trust.
● Partner with Finance, Medical, and Supply Chain to ensure demand forecasting accuracy and ensure business plans align with access timelines.
Capabilities & Competencies
Following the Roche Pharma Operating Principles, the successful candidate must demonstrate:
● Strategic & Systems Thinking: Ability to see the "big picture" and understand how legal, ethical, and commercial developments intersect to impact access.
● Entrepreneurial Mindset: Boldly seeking to identify barriers timeously and providing creative solutions even without perfect information.
● Influencing & Persuasion: Demonstrated ability to engage comfortably with high-level government officials and build consensus across complex matrix organizations.
● Analytical Excellence: Advanced skill in interpreting clinical data, health outcomes, and financial metrics to build compelling value stories.
● Growth Mindset: A commitment to radical simplification, prioritizing impact, and actively seeking feedback to reach full potential.
Qualifications & Experience
Experience:
○ Significant experience (5+ years) in Market Access and Pricing within the pharmaceutical industry.
○ Proven track record of successful reimbursement submissions and negotiations in Bulgaria.
○ Strong organizational and project management skills and the ability to handle multiple, competing projects simultaneously to meet tight deadlines, with outstanding attention to detail.
○ Demonstrated ability to build and maintain relationships with both internal and external stakeholders including executives.
○ Excellent knowledge of the healthcare system and reimbursement regulations.
● Technical Knowledge: Deep understanding of the Bulgarian healthcare landscape, HTA processes, and pharmaceutical regulations.
○ Expertise in Pharmaco-economics, health economics, and value-based pricing models.
● Languages: Fluency in English (written and verbal) is essential
Who we are
A healthier future drives us to innovate. Together, more than 100’000 employees across the globe are dedicated to advance science, ensuring everyone has access to healthcare today and for generations to come. Our efforts result in more than 26 million people treated with our medicines and over 30 billion tests conducted using our Diagnostics products. We empower each other to explore new possibilities, foster creativity, and keep our ambitions high, so we can deliver life-changing healthcare solutions that make a global impact.
Let’s build a healthier future, together.
Roche is an Equal Opportunity Employer.
Skills Required
- Significant experience in Market Access and Pricing within the pharmaceutical industry
- Proven track record of successful reimbursement submissions and negotiations in Bulgaria
- Strong organizational and project management skills
- Demonstrated ability to build and maintain relationships with internal and external stakeholders
- Excellent knowledge of the healthcare system and reimbursement regulations
- Deep understanding of the Bulgarian healthcare landscape, HTA processes, and pharmaceutical regulations
- Fluency in English (written and verbal)
Roche Compensation & Benefits Highlights
The following summarizes recurring compensation and benefits themes identified from responses generated by popular LLMs to common candidate questions about Roche and has not been reviewed or approved by Roche.
-
Retirement Support — U.S. materials describe a 401(k) with both matching and an additional company contribution, supported by formal plan documents and true‑up features. This structure is positioned as a standout element of the total package, particularly at Genentech.
-
Leave & Time Off Breadth — Time‑off provisions include substantial vacation, a year‑end shutdown, and a paid six‑week sabbatical after six years. These elements indicate a recharge‑oriented approach within the U.S. offering.
-
Healthcare Strength — Company materials emphasize comprehensive medical, dental, vision, and mental‑health resources alongside well‑being programs. Benefits pages consistently highlight breadth across core health coverage elements.
Roche Insights
What We Do
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI).
